» Articles » PMID: 27659446

Organic Cation Transporter 3 (OCT3) is Localized to Intracellular and Surface Membranes in Select Glial and Neuronal Cells Within the Basolateral Amygdaloid Complex of Both Rats and Mice

Overview
Specialty Neurology
Date 2016 Sep 24
PMID 27659446
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Organic cation transporter 3 (OCT3) is a high-capacity, low-affinity transporter that mediates corticosterone-sensitive uptake of monoamines including norepinephrine, epinephrine, dopamine, histamine and serotonin. OCT3 is expressed widely throughout the amygdaloid complex and other brain regions where monoamines are key regulators of emotional behaviors affected by stress. However, assessing the contribution of OCT3 to the regulation of monoaminergic neurotransmission and monoamine-dependent regulation of behavior requires fundamental information about the subcellular distribution of OCT3 expression. We used immunofluorescence and immuno-electron microscopy to examine the cellular and subcellular distribution of the transporter in the basolateral amygdaloid complex of the rat and mouse brain. OCT3-immunoreactivity was observed in both glial and neuronal perikarya in both rat and mouse amygdala. Electron microscopic immunolabeling revealed plasma membrane-associated OCT3 immunoreactivity on axonal, dendritic, and astrocytic processes adjacent to a variety of synapses, as well as on neuronal somata. In addition to plasma membrane sites, OCT3 immunolabeling was also observed associated with neuronal and glial endomembranes, including Golgi, mitochondrial and nuclear membranes. Particularly prominent labeling of the outer nuclear membrane was observed in neuronal, astrocytic, microglial and endothelial perikarya. The localization of OCT3 to neuronal and glial plasma membranes adjacent to synaptic sites is consistent with an important role for this transporter in regulating the amplitude, duration, and physical spread of released monoamines, while its localization to mitochondrial and outer nuclear membranes suggests previously undescribed roles for the transporter in the intracellular disposition of monoamines.

Citing Articles

Hippocampal γCaMKII dopaminylation promotes synaptic-to-nuclear signaling and memory formation.

Stewart A, Fulton S, Durand-de Cuttoli R, Thompson R, Chen P, Brindley E bioRxiv. 2024; .

PMID: 39345578 PMC: 11430047. DOI: 10.1101/2024.09.19.613951.


CNS Viral Infections-What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches.

Sun M, Manson M, Guo T, de Lange E CNS Drugs. 2024; 38(5):349-373.

PMID: 38580795 PMC: 11026214. DOI: 10.1007/s40263-024-01082-3.


Metabolite transport across central nervous system barriers.

Carstens G, Verbeek M, Rohlwink U, Figaji A, Te Brake L, van Laarhoven A J Cereb Blood Flow Metab. 2024; 44(7):1063-1077.

PMID: 38546534 PMC: 11179608. DOI: 10.1177/0271678X241241908.


Organic cation transporters in psychiatric and substance use disorders.

Honan L, Fraser-Spears R, Daws L Pharmacol Ther. 2023; 253:108574.

PMID: 38072333 PMC: 11052553. DOI: 10.1016/j.pharmthera.2023.108574.


Histone H3 dopaminylation in nucleus accumbens, but not medial prefrontal cortex, contributes to cocaine-seeking following prolonged abstinence.

Stewart A, Lepack A, Fulton S, Safovich P, Maze I Mol Cell Neurosci. 2023; 125:103824.

PMID: 36842545 PMC: 10247417. DOI: 10.1016/j.mcn.2023.103824.


References
1.
Cui M, Aras R, Christian W, Rappold P, Hatwar M, Panza J . The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A. 2009; 106(19):8043-8. PMC: 2683105. DOI: 10.1073/pnas.0900358106. View

2.
Gasser P, Lowry C, Orchinik M . Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci. 2006; 26(34):8758-66. PMC: 6674371. DOI: 10.1523/JNEUROSCI.0570-06.2006. View

3.
Inazu M, Takeda H, Ikoshi H, Sugisawa M, Uchida Y, Matsumiya T . Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem Int. 2001; 39(1):39-49. DOI: 10.1016/s0197-0186(01)00010-9. View

4.
Stutzmann G, McEwen B, LeDoux J . Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone. J Neurosci. 1998; 18(22):9529-38. PMC: 6792882. View

5.
Pinto A, Sesack S . Ultrastructural analysis of prefrontal cortical inputs to the rat amygdala: spatial relationships to presumed dopamine axons and D1 and D2 receptors. Brain Struct Funct. 2008; 213(1-2):159-75. DOI: 10.1007/s00429-008-0180-6. View